Does MEROPENEM Cause Hepatic lesion? 13 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Hepatic lesion have been filed in association with MEROPENEM (Meropenem). This represents 0.1% of all adverse event reports for MEROPENEM.
13
Reports of Hepatic lesion with MEROPENEM
0.1%
of all MEROPENEM reports
1
Deaths
4
Hospitalizations
How Dangerous Is Hepatic lesion From MEROPENEM?
Of the 13 reports, 1 (7.7%) resulted in death, 4 (30.8%) required hospitalization, and 2 (15.4%) were considered life-threatening.
Is Hepatic lesion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MEROPENEM. However, 13 reports have been filed with the FAERS database.
What Other Side Effects Does MEROPENEM Cause?
Drug ineffective (2,802)
Off label use (1,572)
Condition aggravated (706)
Pyrexia (669)
Multiple organ dysfunction syndrome (655)
Drug reaction with eosinophilia and systemic symptoms (626)
Septic shock (613)
Drug resistance (539)
Acute kidney injury (522)
Rash (437)
What Other Drugs Cause Hepatic lesion?
OCTREOTIDE (296)
EVEROLIMUS (171)
RIBOCICLIB (144)
LETROZOLE (139)
CAPECITABINE (124)
ADALIMUMAB (123)
METHOTREXATE (108)
FULVESTRANT (107)
PALBOCICLIB (104)
CYCLOPHOSPHAMIDE (101)
Which MEROPENEM Alternatives Have Lower Hepatic lesion Risk?
MEROPENEM vs MEROPENEM ANHYDROUS
MEROPENEM vs MESALAMINE
MEROPENEM vs MESNA
MEROPENEM vs METAMIZOLE
MEROPENEM vs METARAMINOL